Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBT (2016 - 2025)

Historic EBT for Alkermes (ALKS) over the last 16 years, with Q3 2025 value amounting to $100.7 million.

  • Alkermes' EBT fell 860.47% to $100.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $401.0 million, marking a year-over-year increase of 2070.73%. This contributed to the annual value of $443.8 million for FY2024, which is 527.4% up from last year.
  • As of Q3 2025, Alkermes' EBT stood at $100.7 million, which was down 860.47% from $104.8 million recorded in Q2 2025.
  • Alkermes' EBT's 5-year high stood at $281.8 million during Q2 2023, with a 5-year trough of -$67.4 million in Q3 2022.
  • Moreover, its 5-year median value for EBT was $58.3 million (2023), whereas its average is $60.7 million.
  • As far as peak fluctuations go, Alkermes' EBT crashed by 131053.83% in 2021, and later soared by 94760.6% in 2023.
  • Alkermes' EBT (Quarter) stood at $127.3 million in 2021, then decreased by 10.04% to $114.5 million in 2022, then tumbled by 49.06% to $58.3 million in 2023, then surged by 191.32% to $169.9 million in 2024, then plummeted by 40.7% to $100.7 million in 2025.
  • Its EBT was $100.7 million in Q3 2025, compared to $104.8 million in Q2 2025 and $25.5 million in Q1 2025.